Buy Norditropin FlexPro Pen (10 mg, 180 IU) as a six-pen pack through HGH Meds. Each package contains six Novo Nordisk FlexPro pens with 10 mg, or approximately 30 IU, of somatropin per pen, for a total of 180 IU.
Norditropin is an FDA-approved prescription human growth hormone manufactured by Novo Nordisk. The FlexPro delivery system comes prefilled with medication, so patients do not need to mix HGH powder with bacteriostatic water before use.
HGH Meds operates as a COFEPRIS-licensed hormone clinic in Mexico. Norditropin is available following an in-person clinical evaluation and prescription from a licensed provider.
This six-pack provides a larger supply of the 10 mg FlexPro pen for patients whose prescribed treatment plan requires multiple pens.
✓ Manufacturer: Novo Nordisk
✓ Medication: Norditropin (somatropin)
✓ Pen size: 10 mg, approximately 30 IU per pen
✓ Package quantity: 6 FlexPro pens
✓ Total amount: 60 mg, approximately 180 IU
✓ Format: Prefilled injectable pen
✓ Administration: Subcutaneous injection
✓ Prescription required: Yes
Your provider will determine your prescribed dosage and how many pens are appropriate for your treatment plan.
Norditropin FlexPro is a prefilled injection pen containing somatropin, a recombinant form of human growth hormone designed to match the growth hormone naturally produced by the body.
The FlexPro format eliminates the reconstitution step required by some other HGH products. The medication is already inside the pen, and the built-in dose counter and display allow patients to see the selected dose before administering an injection.
For patients prescribed Norditropin, this design can make preparing and administering each dose more straightforward.
This product includes six individual Norditropin FlexPro 10 mg pens.
Each pen contains:
✓ 10 mg of Norditropin somatropin
✓ Approximately 30 IU of HGH
✓ A prefilled medication reservoir
✓ An integrated dose selector
✓ A dose counter and display window
Together, the six pens contain approximately 180 IU of Norditropin.
Injection needles are used with the FlexPro device but are separate from the medication pen. Your provider can explain which compatible needles and supplies are required for your prescribed treatment.
The FlexPro pen is designed to reduce the number of preparation steps involved in administering Norditropin.
Key features include:
| Feature | Description |
|---|---|
| Prefilled medication | There is no need to combine HGH powder with bacteriostatic water before use. |
| Visible dose counter | The pen displays the selected dose, making it easier to confirm the amount before injection. |
| Adjustable dosing | The dose selector allows the prescribed amount to be set directly on the device. |
| Self-contained design | Medication and the dosing mechanism are contained within one compact pen. |
| Established manufacturer | Norditropin is produced by Novo Nordisk, a global pharmaceutical company. |
Patients should follow the Instructions for Use supplied with Norditropin as well as the directions provided by their clinician.
Novo Nordisk has offered Norditropin through several injection devices over the years, including older NordiLet products. While the delivery systems have changed, these devices were designed to administer Norditropin somatropin.
The FlexPro pen uses a visible dose counter and selector rather than requiring the patient to determine a dose based only on a series of clicks. It also arrives prefilled with medication.
Patients switching between devices should follow the instructions for their specific pen rather than relying on instructions for an older Norditropin device.
Norditropin is a prescription human growth hormone medication used for certain conditions involving insufficient growth hormone or impaired growth.
FDA-approved uses include growth hormone deficiency in adults and several pediatric growth disorders. A licensed provider must evaluate the patient to determine whether Norditropin is medically appropriate and establish the correct dosage.
Norditropin should only be used according to a prescribed treatment plan.
Norditropin FlexPro is administered as a subcutaneous injection. Common injection areas include the abdomen, thigh, buttocks, and back of the upper arm.
Injection sites should be rotated rather than repeatedly using the same location. Patients should follow the official Norditropin Instructions for Use and the directions provided by their clinician for preparing the pen, selecting the prescribed dose, attaching a compatible needle, administering the injection, and safely disposing of the needle afterward.
Do not change your prescribed dose without speaking with your healthcare provider.
HGH Meds provides Norditropin through a COFEPRIS-licensed hormone clinic in Mexico. Because Norditropin is a prescription medication, patients must complete an in-person clinical evaluation before medication can be prescribed and dispensed.
The 180 IU package contains six FlexPro 10 mg pens and may be appropriate when a clinician has prescribed a treatment plan requiring multiple pens. The amount of medication needed depends on the prescribed dosage and duration of treatment.
Patients who are new to HGH Meds may have different dispensing limits, so speak with the clinical team about the quantity appropriate for your treatment plan.
The package contains six Norditropin FlexPro pens. Each pen contains 10 mg, or approximately 30 IU, for approximately 180 IU total. Other quantities of pens are available through HGH Meds, including:
This product was added to our catalog on Monday 25 June, 2012.
For more information, please visit this product's webpage.